As a Free StocksGuide user, you can view scores for all 7,039 stocks worldwide.
17 Analysts have issued a Shionogi & forecast:
17 Analysts have issued a Shionogi & forecast:
| Jun '25 |
+/-
%
|
||
| Revenue | 440,463 440,463 |
4%
4%
|
|
| Gross Profit | 378,762 378,762 |
4%
4%
|
|
| EBITDA | 167,159 167,159 |
20%
20%
|
|
| EBIT (Operating Income) EBIT | 163,591 163,591 |
21%
21%
|
|
| Net Profit | 179,153 179,153 |
19%
19%
|
|
In millions JPY.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Shionogi & Co., Ltd. engages in the research, development, supply, manufacture, and sale of pharmaceutical products. Its products include prescription drugs, over-the-counter drugs, diagnostic regents, medical devices and others. The company was founded by Gisaburo Shiono on March 17, 1878 and is headquartered in Osaka, Japan.
| Head office | Japan |
| CEO | Isao Teshirogi |
| Employees | 4,959 |
| Founded | 1878 |
| Website | www.shionogi.com |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.


